Daily Market Movement: Esperion Therapeutics Inc. (ESPR) Sees a 2.92 Increase, Closing at 2.47

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The closing price of Esperion Therapeutics Inc. (NASDAQ: ESPR) was $2.47 for the day, up 2.92% from the previous closing price of $2.40. In other words, the price has increased by $2.92 from its previous closing price. On the day, 9.32 million shares were traded. ESPR stock price reached its highest trading level at $2.6399 during the session, while it also had its lowest trading level at $2.385.

Ratios:

Our analysis of ESPR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.78 and its Current Ratio is at 2.22.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 18 ’24 when Foody Joanne M. sold 3,285 shares for $2.87 per share. The transaction valued at 9,418 led to the insider holds 273,779 shares of the business.

Warren Eric sold 2,540 shares of ESPR for $7,254 on Jun 18 ’24. The Chief Commercial Officer now owns 165,586 shares after completing the transaction at $2.86 per share. On May 17 ’24, another insider, Warren Eric, who serves as the Chief Commercial Officer of the company, sold 192 shares for $2.48 each. As a result, the insider received 477 and left with 168,126 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ESPR now has a Market Capitalization of 467966208 and an Enterprise Value of 790228928. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.83. Its current Enterprise Value per Revenue stands at 3.44 whereas that against EBITDA is -22.862.

Stock Price History:

The Beta on a monthly basis for ESPR is 1.03, which has changed by 0.48795176 over the last 52 weeks, in comparison to a change of 0.24704397 over the same period for the S&P500. Over the past 52 weeks, ESPR has reached a high of $3.40, while it has fallen to a 52-week low of $0.70. The 50-Day Moving Average of the stock is 5.99%, while the 200-Day Moving Average is calculated to be 24.05%.

Shares Statistics:

ESPR traded an average of 8.48M shares per day over the past three months and 12887330 shares per day over the past ten days. A total of 170.42M shares are outstanding, with a floating share count of 154.70M. Insiders hold about 9.23% of the company’s shares, while institutions hold 71.03% stake in the company. Shares short for ESPR as of 1718323200 were 24887802 with a Short Ratio of 2.93, compared to 1715731200 on 24911275. Therefore, it implies a Short% of Shares Outstanding of 24887802 and a Short% of Float of 13.170000000000002.

Most Popular